Package 71921-210-12

Brand: valganciclovir

Generic: valganciclovir
NDC Package

Package Facts

Identity

Package NDC 71921-210-12
Digits Only 7192121012
Product NDC 71921-210
Product ID 71921-210_cc6c4939-7908-439c-b1b8-6b52e826c7a5
Description

1 BOTTLE in 1 CARTON (71921-210-12) / 100 mL in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2023-07-01
Brand valganciclovir
Generic valganciclovir
Sample Package No

Linked Drug Pages (1)

Valganciclovir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "cc6c4939-7908-439c-b1b8-6b52e826c7a5", "openfda": {"nui": ["N0000175461", "N0000020060", "N0000175459"], "unii": ["GCU97FKN3R"], "rxcui": ["863559"], "spl_set_id": ["cc6c4939-7908-439c-b1b8-6b52e826c7a5"], "pharm_class_epc": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (71921-210-12)  / 100 mL in 1 BOTTLE", "package_ndc": "71921-210-12", "marketing_start_date": "20230701"}], "brand_name": "Valganciclovir", "product_id": "71921-210_cc6c4939-7908-439c-b1b8-6b52e826c7a5", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "71921-210", "generic_name": "Valganciclovir", "labeler_name": "Florida Pharmaceutical Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valganciclovir", "active_ingredients": [{"name": "VALGANCICLOVIR", "strength": "50 mg/mL"}], "application_number": "ANDA216317", "marketing_category": "ANDA", "marketing_start_date": "20230701", "listing_expiration_date": "20261231"}